D

Dracen Pharmaceuticals, Inc.

11 employees

Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Health Care
Pharmaceutical

Date founded

2016

Funding rounds raised

Total raised

$40M

from 2 investors over 2 rounds

D

Dracen Pharmaceuticals, Inc. raised $40M on March 22, 2018

Investors: i&i Prague and Osage University Partners (OUP)

FAQ